Private company
Biohaven Pharmaceutical Holding Co Ltd.
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2021
80.2%Gross margin3
-152.2%Operating margin3
-183.0%Net margin3
626.9%Revenue growth, 20213
-$832.8MFree cash flow3
Where the money goes
Where each dollar of revenue went, fiscal 2021
- Cost of revenue8¢$91.7M
- Research and development31¢$361.3M
- Selling, general and admin61¢$713.5M
- Income tax0¢$5.1M
Out of $462.5M in revenue.3 The company lost money this year.
Financial statements
No quarterly figures reported.
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | $04 | $03 | $63.6M3 | $462.5M3 | |||
| Cost of revenue | $04 | $03 | $17.7M3 | $91.7M3 | |||
| Gross profit | $04 | $03 | $45.9M3 | $370.8M3 | |||
| Research and development | $7.6M5 | $55.5M6 | $89.4M7 | $190.0M4 | $344.7M3 | $229.0M3 | $361.3M3 |
| Selling, general and admin | $34.6M4 | $134.4M3 | $462.3M3 | $713.5M3 | |||
| Operating income | -$9.7M5 | -$60.6M6 | -$107.6M7 | -$224.6M4 | -$479.1M3 | -$645.4M3 | -$704.0M3 |
| Interest | $385.0K6 | $906.0K6 | $38.0K6 | ||||
| Income tax | $90.0K6 | $1.0M7 | $467.0K4 | $419.0K3 | $10.2M3 | $5.1M3 | |
| Net income | -$10.1M5 | -$63.5M6 | -$127.2M7 | -$240.9M4 | -$528.8M3 | -$766.8M3 | -$846.6M3 |
| Earnings per share | -$10.913 | -$13.063 | -$13.093 | ||||
| Earnings per share (diluted) | -$10.913 | -$13.063 | -$13.093 |
No quarterly figures reported.
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Cash | $1.5M6 | $23.7M6 | $131.5M6 | $264.2M7 | $316.7M3 | $132.1M3 | $171.9M3 |
| Current assets | $24.0M5 | $136.7M6 | $272.3M7 | $328.3M4 | $603.4M3 | $876.3M3 | |
| Total assets | $27.0M5 | $146.9M6 | $290.0M7 | $344.3M4 | $687.0M3 | $1.1B3 | |
| Current liabilities | $7.9M5 | $9.4M6 | $19.5M7 | $66.2M4 | $277.6M3 | $534.2M3 | |
| Long-term debt | $04 | $267.5M3 | $626.7M3 | ||||
| Total liabilities | $28.8M5 | $14.9M6 | $139.1M7 | $351.7M4 | $1.0B3 | $1.8B3 | |
| Shareholders’ equity | $1.1M6 | -$45.0M7 | $132.0M7 | $150.9M7 | -$7.4M4 | -$390.4M3 | -$739.4M3 |
| Shares outstanding | 13.1M shares5 | 36.1M shares6 | 44.2M shares7 | 44.2M shares4 | 60.4M shares3 | 66.9M shares3 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Compare Biohaven Pharmaceutical Holding Co Ltd. with another company
Recent filings
- Oct 5, 20224 PRIMARY DOCUMENT
- Oct 3, 20228-K
- Oct 3, 20224 PRIMARY DOCUMENT
- Oct 3, 20224 PRIMARY DOCUMENT
- Oct 3, 20224 PRIMARY DOCUMENT
- Oct 3, 20224 PRIMARY DOCUMENT
- Oct 3, 20224 PRIMARY DOCUMENT
- Oct 3, 20224 PRIMARY DOCUMENT
- Oct 3, 20224 PRIMARY DOCUMENT
- Oct 3, 20224 PRIMARY DOCUMENT
- Oct 3, 20224 PRIMARY DOCUMENT
- Oct 3, 20224 PRIMARY DOCUMENT
- Oct 3, 20224 PRIMARY DOCUMENT
- Oct 3, 20224 PRIMARY DOCUMENT
- Oct 3, 20224 PRIMARY DOCUMENT
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7